Preferred Label : cabotegravir;
Origin ID : M000623417;
Broader MeSH concept(s)
- N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide [MeSH concept]
- Currated CISMeF NLP mapping
- MeSH narrower concept(s)
- Related record
https://www.has-sante.fr/jcms/p_3263063/fr/vocabria-cabotegravir
2021
false
false
false
France
cabotegravir
administration, oral
injections, intramuscular
treatment outcome
drug approval
guidelines for drug use
HIV-1
drug therapy, combination
hiv infections
adult
Rilpivirine
HIV integrase inhibitors
evaluation of the transparency committee
cabotegravir
cabotegravir
pyridones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vocabria
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabotegravir
cabotegravir
drug approval
europe
cabotegravir
HIV integrase inhibitors
HIV integrase inhibitors
drug antagonism
hiv infections
HIV-1
Rilpivirine
adult
administration, oral
injections, intramuscular
Delayed-Action preparations
Cabotegravir Sodium
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
cabotegravir
cabotegravir
pyridones
pyridones
---
